लोड हो रहा है...
IL-2 and Beyond in Cancer Immunotherapy
The development of the T- and natural killer (NK) cell growth factor IL-2 has been a sentinel force ushering in the era of immunotherapy in cancer. With the advent of clinical grade recombinant IL-2 in the mid-1980s, oncologists could for the first time directly manipulate lymphocyte populations wit...
में बचाया:
| में प्रकाशित: | J Interferon Cytokine Res |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Mary Ann Liebert, Inc.
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5815463/ https://ncbi.nlm.nih.gov/pubmed/29443657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jir.2017.0101 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|